Søholm B
Sano-Pharm A/S, Vedbaek, Denmark.
Adv Ther. 1998 Jan-Feb;15(1):54-65.
Ginkgo biloba is a plant extract used to alleviate symptoms associated with cognitive deficits, e.g., decreased memory performance, lack of concentration, decreased alertness, tinnitus, and dizziness. Pharmacologic studies have shown that the therapeutic effect of ginkgo is based on several active constituents with vasoactive and free radical-scavenging properties. The use of ginkgo extract in either dementias of the Alzheimer or multi-infarct type or in the case of cerebral insufficiency, a symptom complex related to age-dependent impairment of cerebral circulation, is based mainly on positive results from good-quality placebo-controlled studies that enrolled approximately 1,200 patients with criteria established by International Classification of Diseases (9th and 10th revisions, ICD-9 and ICD-10) or the 3rd revision of the Diagnostic and Statistical Manual (DSM-III-R) (uncomplicated dementia). Effect on cognitive symptoms was within the range of a 25% reduction. Memory, concentration, and alertness were the first symptoms to be relieved, with tinnitus and dizziness improving somewhat later. A minimum of 4 to 6 weeks were needed before a pronounced effect could be expected. The pharmacologic advantage of ginkgo seems to be a very tolerable side-effect profile, with a side-effect frequency at the placebo level.
银杏叶是一种植物提取物,用于缓解与认知缺陷相关的症状,如记忆力下降、注意力不集中、警觉性降低、耳鸣和头晕。药理学研究表明,银杏叶的治疗作用基于几种具有血管活性和自由基清除特性的活性成分。银杏叶提取物用于治疗阿尔茨海默病或多发性梗死型痴呆,或用于治疗脑供血不足(一种与年龄相关的脑循环障碍相关的症状复合体),主要基于高质量安慰剂对照研究的阳性结果,这些研究纳入了约1200名符合国际疾病分类(第9版和第10版,ICD - 9和ICD - 10)或《精神疾病诊断与统计手册》第3版修订本(DSM - III - R)(单纯性痴呆)标准的患者。对认知症状的影响在减轻25%的范围内。记忆力、注意力和警觉性是最先缓解的症状,耳鸣和头晕随后有所改善。在预期有明显效果之前,至少需要4至6周。银杏叶的药理学优势似乎是副作用非常轻微,副作用发生率与安慰剂相当。